Lung cancer is one of the leading causes of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all cases. The discovery of specific genetic alterations in NSCLC has significantly improved the management and prognosis of patients with this disease. Among these genetic alterations, mutations in the ALK1 and ROS1 […]











